ΔΎΉΟΦ±²₯

Video

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

β€” And nearly half of responders to enfortumab vedotin plus pembrolizumab remained in remission

image

Latest in Video

Sequencing in Advanced Urothelial Carcinoma

Navigating second-line options

Nov 01, 2024
"I'm Doing Great, So When Can I Stop My Atopic Dermatitis Treatment?"

Our panel of experts discuss when might be the right time to reduce therapy

Dec 08, 2023
DermGPT Looks to Improve Clinic Productivity for Dermatologists

Faranak Kamangar on how the AI tool can be used in practice to make life easier for physicians

Dec 08, 2023
Managing the Safety of Newer Atopic Dermatitis Treatments

Our panel of experts discuss how they monitor patients on biologics and JAK inhibitors

Dec 01, 2023
DermGPT Looks to Improve Clinic Productivity for Dermatologists

Faranak Kamangar on how the AI tool can be used in practice to make life easier for physicians

Managing the Safety of Newer Atopic Dermatitis Treatments

Our panel of experts discuss how they monitor patients on biologics and JAK inhibitors

More in Video

Biologics Offer New Options in Atopic Dermatitis

Peter Lio, MD, says he can't wait to have more flexibility for his pediatric patients

Dec 01, 2023
image
Tralokinumab Controls Moderate-to-Severe AD Over the Long Term

Steven Feldman, MD, PhD, highlights the importance of improving quality of life

Nov 27, 2023
image
How and When to Escalate Treatment for Eczema

Our panel of experts discuss the appropriate time to introduce systemic therapy or switch agents

Nov 26, 2023
image
Future of Atopic Dermatitis Management

Our understanding of eczema's potential comorbidities will likely expand, says Lakshi Aldredge

Nov 25, 2023
image
Improving Treatment Adherence in Atopic Dermatitis

We've got great treatments, says Steven Feldman, the key is getting patients to use them

Nov 20, 2023
image
The Landscape of New Treatments for Eczema

Our panel of experts discuss the "explosion" in new systemic and topical agents

Nov 17, 2023
image
Staying Up-to-Date on Approved Therapies in Atopic Dermatitis

James Del Rosso, DO, says to keep an open mind when determining the best option for patients

Nov 17, 2023
image
IL-13 Blocker for Eczema Maintains Efficacy at Less-Frequent Dosing

Will be good news for patients when drug is approved, says Emma Guttman-Yassky, MD, PhD

Nov 13, 2023
image
Transitioning Patients With Atopic Dermatitis From Topical to Systemic Therapy

Peter Lio, MD, discusses how he approaches that decision-making discussion

Nov 06, 2023
image
The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer

Roy Herbst, MD, PhD, leads a discussion on ADCs targeting TROP2, HER2, and HER3

Oct 30, 2023
image
Targeting KRAS in NSCLC: Recent Progress and New Approaches

Roy Herbst, MD, PhD, leads a discussion on current and emerging treatments available

Oct 23, 2023
image
Perioperative Approaches to Lung Cancer

Roy Herbst, MD, PhD, leads a discussion on the newest targeted and immunotherapies

Oct 16, 2023
image
What's New in Targeted Lung Cancer Treatment?

Roy Herbst, MD, PhD, leads a discussion on new data coming down the pike

Oct 09, 2023
image
Upcoming Studies on Dupilumab for Alopecia Areata

Results may lead to an alternative to JAK inhibitors

Sep 27, 2023
image
More in Video